Identification of Cells Responding to Vasoactive Intestinal Peptide by Measuring Intracellular Cyclic Adenosine Monophosphate in Human Colonic Mucosa

References

• Ulrich II CD, Holtmann M, Miller LJ. Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. Gastroenterology 1998;114:382–97.
   Google Scholar
• Kimura M, Masuda T, Hiwatashi N, Toyota T, Nagura H. Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease. Pathol Int 1994; 44:624–34.
   Google Scholar
• Todorovic V, Janic B, Koko V, Micev M, Nikolic JA, Ratkovic M, et al. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis—a radioimmunoassay and immunohistochemi-cal study. Hepatogastroenterology 1996;43:483–8.
   PubMedGoogle Scholar
• Dupont C, Laburthe M, Broyart JP, Bataille D, Rosselin G. Cyclic AMP production in isolated colonic epithelial crypts: a highly sensitive model for the evaluation of vasoactive intestinal peptide action in human intestine. Eur J Clin Invest 1980;10:67–76.
   Google Scholar
• Guerrero JM, Prieto JC, Elorza FL, Ramirez R, Goberna R. Interaction of vasoactive intestinal peptide with human blood mononuclear cells. Mol Cell Endocrinol 1981;21:151–60.
   PubMed Web of Science ®Google Scholar
• Ottaway CA, Bernaerts C, Chan B, Greenberg GR. Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells. Can J Physiol Pharmacol 1983;61:664–71.
   PubMed Web of Science ®Google Scholar
• Calvo JR, Guerrero JM, Molinero P, Blasco R, Goberna R. Interaction of vasoactive intestinal peptide (VIP) with human peripheral blood lymphocytes: specific binding and cyclic AMP production. Gen Pharmacol 1986;17:185–9.
   Google Scholar
• O’Dorisio MS, Hermina NS, O’Dorisio TM, Balcerzak SP. Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase. J Immunol 1981;127:2551–4.
   Google Scholar
• Chedeville A, Mirossay L, Chastre E, Hurbain-Kosmath I, Lopez M, Gespach C. Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages. FEBS Lett 1993;319:171–6.
   Google Scholar
• Annibale B, Fais S, Boirivant M, Pallone F, Delle Fave G. Presence of high affinity class of receptors for VIP on human intestinal lymphocytes. Gastroenterology 1988;94:A9.
   Google Scholar
• Youngman KR, Simon PL, West GA, Cominelli F, Rachmilewitz D, Klein JS, et al. Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 1993;104:749–58.
   PubMed Web of Science ®Google Scholar
• Bull DM, Bookman MA. Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest 1977;59:966–74.
   PubMed Web of Science ®Google Scholar
• Fiocchi C. Lymphoid cells of the gastrointestinal tract. Isolation procedures. Acta Chir Scand 1985;Suppl 525:11–23.
   Google Scholar
• Sreedharan SP, Patel DR, Huang J-X, Goetzl EJ. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. Biochem Biophys Res Commun 1993;193:546–53.
   Google Scholar
• Muscettola M, Grasso G. Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells. Immunobiology 1990;180:419–30.
   PubMed Web of Science ®Google Scholar
• Ganea D, Sun L. Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFN-gamma from stimulated murine T lymphocytes. J Neuroimmunol 1993;47:147–58.
   PubMed Web of Science ®Google Scholar
• Sun L, Ganea D. Vasoactive intestinal peptide inhibits interleukin (IL) -2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex. J Neuroimmunol 1993;48:59–70.
   PubMed Web of Science ®Google Scholar
• Litwin DK, Wilson AK, Said SI. Vasoactive intestinal polypeptide (VIP) inhibits rat alveolar macrophage phagocytosis and chemotaxis in vitro. Regul Pept 1992;40:63–74.
   Google Scholar
• Sirianni MC, Annibale B, Tagliaferri F, Fais S, De Luca S, Pallone F, et al. Modulation of human natural killer activity by vasoactive intestinal peptide (VIP) family. VIP, glucagon and GHRF specifically inhibit NK activity. Regul Pept 1992;38:79–87.
   Google Scholar
• Nagura H, Kimura M, Kubota M, Kimura N. Neuroendocrine-immune interactions in the gastrointestinal tract. In: Berczi I, editor. Advances in psychoneuroimmunology. New York: Plenum Press; 1994. p. 253–61.
   Google Scholar
• Ottaway CA. Neuroimmunomodulation in the intestinal mucosa. Gastroenterol Clin North Am 1991;20:511–29.
   PubMed Web of Science ®Google Scholar
• Elitsur Y, Luk GD. Gastrointestinal neuropeptides suppress human colonic lamina propria lymphocyte DNA synthesis. Peptides 1990;11:879–84.
   PubMed Web of Science ®Google Scholar
• Van Tol EAF, Verspaget HW, Hansen BE, Lamers CBHW. Neuroenteric peptides affect natural killer activity by intestinal lamina propria mononuclear cells. J Neuroimmunol 1993;42: 139–46.
   PubMed Web of Science ®Google Scholar
• Pallone F, Fais S, Annibale B, Boirivant M, Morace S, Delle Fave G. Modulatory effects of somatostatin and vasoactive intestinal peptide on human intestinal lymphocytes. Ann NY Acad Sci 1990;594:408–10.
   Google Scholar
• Svoboda M, Tastenoy M, Van Rampelbergh J, Goossens J-F, De Neef P, Wealbroeck M, et al. Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem Biophys Res Commun 1994;205: 1617–24.
   Google Scholar
• Adamou JE, Aiyar N, Van Horn S, Elshourbagy NA. Cloning and functional characterization of the human vasoactive intestinal peptide (VIP) -2 receptor. Biochem Biophys Res Commun 1995;209:385–92.
   PubMed Web of Science ®Google Scholar
• Elson CO, McCabe RP. The immunology of inflammatory bowel disease. In: Kirsner JB, Shorter RG, editors. Inflammatory bowel disease. 4th ed. Baltimore: Williams and Wilkins; 1995. p. 203–51.
   Google Scholar
• Abuzakouk M, Feighery C, O’Farrelly C. Collagenase and dispase enzymes disrupt lymphocyte surface molecules. J Immunol Meth 1996;194:211–6.
   Google Scholar
• Sreedharan SP, Patel DR, Xia M, Ichikawa S, Goetzl EJ. Human vasoactive intestinal peptide1 receptors expressed by stable transfectants couple to two distinct signaling pathways. Biochem Biophys Res Commun 1994;203: 141–8.
   Google Scholar
• Spessert R. Vasoactive intestinal peptide stimulation of cyclic guanosine monophosphate formation: further evidence for a role of nitric oxide synthase and cytosolic guanylate cyclase in rat pinealocytes. Endocrinology 1993;132:2513–7.
   PubMed Web of Science ®Google Scholar
• Jin JG, Murthy KS, Grider JR, Makhlouf GM. Activation of distinct cAMP- and cGMP-dependent pathways by relaxant agents in isolated gastric muscle cells. Am J Physiol 1993;264:G470–7.
   Google Scholar
• Chakder S, Rattan S. Involvement of cAMP and cGMP in relaxation of internal anal sphincter by neural stimulation, VIP, and NO. Am J Physiol 1993;264:G702–7.
   Google Scholar
• Lelievre V, Meunier AC, Caigneaux E, Falcon J, Muller JM. Differential expression and function of PACAP and VIP receptors in four human colonic adenocarcinoma cell lines. Cell Signal 1998;10:13–26.
   Google Scholar